Menu

Osteoporosis Management In Women Who Had a Fracture (OMW)

Osteoporosis Management in Women Who Had a Fracture: Assesses women 67–85 years of age who suffered a fracture and who had either a bone mineral density test or a prescription for a drug to treat osteoporosis in the six months after the fracture.

Why It Matters

Osteoporosis is a serious disease affecting mostly older adults that can impact their quality of life. Osteoporosis is a bone disease characterized by low bone mass, which leads to bone fragility and increased susceptibility to fractures of the hip, spine and wrist.1 Osteoporotic fractures, particularly hip fractures, are associated with chronic pain and disability, loss of independence, decreased quality of life and increased mortality.2 With appropriate screening and treatment, the risk of future osteoporosis-related fractures can be reduced.

Historical Results – National Averages

Get Access to the Historical Results

By completing the form below, you’ll gain free access to national performance data.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

References

  1. National Institutes of Health. Osteoporosis and Related Bone Diseases National Resource Center (NIH NIAMS). October 2019. “Osteoporosis: Overview.”
  2. S. Preventive Services Task Force. 2018. Final Recommendation Statement: Osteoporosis to Prevent Fractures: Screening.

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

    Print this page.